Get the latest SUPG - Supergen Incorporated stock market performance data and financial news.
Read Jim Cramer's take on Supergen Incorporated (SUPG) and get his latest thoughts on the company?s performance and outlook
Get the latest SUPG - Supergen Incorporated together with stock market performance data and financial news.
Get the latest SUPG - Supergen Incorporated stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Cramer says it's worth waiting for this stock to drop down before buying.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10242205/1/cramers-mad-money-lightning-round-dells-a-tough-call.html
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10580181/1/insider-buys-5m-worth-of-americredit.html
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10591828/1/hugoton-royalty-chair-buys-4m-worth.html
Dacogen's failed trial in myelodysplastic syndromes opens the door to greater market share for Celgene's Vidaza.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10424196/1/supergen-bust-a-boon-for-celgene-update.html
Dacogen failed a late-stage trial in myelodysplastic syndromes, but that's good news for the fall launch of Celgene's Vidaza.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10424107/1/a-negative-for-supergen-a-plus-for-celgene.html
Connect with TheStreet